Insider Transactions in Q4 2023 at Adma Biologics, Inc. (ADMA)
Insider Transaction List (Q4 2023)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 31
2023
|
Adam S Grossman President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
23,057
-1.02%
|
$92,228
$4.52 P/Share
|
Dec 31
2023
|
Brian Lenz EVP, CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,908
-2.21%
|
$67,632
$4.52 P/Share
|